Related Experiment Video
Updated: Jun 28, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
Kidney disease in patients with HIV infection and AIDS
Jonathan Winston1, Gilbert Deray, Trevor Hawkins
1Mount Sinai School of Medicine, New York, New York, USA.
Insights
Kidney disease is a growing concern for people with human immunodeficiency virus (HIV) on antiretroviral therapy. Early detection and aggressive management of risk factors like hypertension and diabetes are crucial for better outcomes.
Area of Science:
- Nephrology
- Infectious Diseases
- Public Health
Background:
- Antiretroviral therapy has increased longevity for human immunodeficiency virus (HIV)-infected patients.
- Kidney diseases are now a major cause of illness and death in this population.
- Risk factors include older age, black race, hypertension, diabetes, low CD4(+) count, and high viral load.
Purpose of the Study:
- To review the current understanding of kidney disease in HIV-infected patients.
- To highlight risk factors and diagnostic strategies.
- To discuss the role of antiretroviral therapy in kidney disease.
Main Methods:
- Literature review of clinical trials and observational studies.
- Analysis of risk factors for kidney disease in HIV patients.
- Discussion of diagnostic markers like glomerular filtration rate and creatinine clearance.
Main Results:
- Key risk factors for kidney disease in HIV patients identified.
- Antiretroviral regimens, including tenofovir, are being studied for kidney impact.
- Incidence of kidney disease related to tenofovir is low in current studies.
Conclusions:
- Early diagnosis and aggressive management of hypertension and diabetes are essential.
- Continued research into race-specific kidney disease risks and early detection strategies is needed.
- Optimizing antiretroviral therapy and monitoring kidney function can reduce morbidity and mortality.
Abstract:
As patients infected with human immunodeficiency virus (HIV) live longer while receiving antiretroviral therapy, kidney diseases have emerged as significant causes of morbidity and mortality. Black race, older age, hypertension, diabetes, low CD4(+) cell count, and high viral load remain important risk factors for kidney disease in this population. Chronic kidney disease should be diagnosed in its early stages through routine screening and careful attention to changes in glomerular filtration rate or creatinine clearance. Hypertension and diabetes must be aggressively treated. Antiretroviral regimens themselves have been implicated in acute or chronic kidney disease. The risk of kidney disease associated with the widely used agent tenofovir continues to be studied, although its incidence in reported clinical trials and observational studies remains quite low. Future studies about the relationship between black race and kidney disease, as well as strategies for early detection and intervention of kidney disease, hold promise for meaningful reductions in morbidity and mortality associated with kidney disease.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Chronic Kidney Disease I: Introduction
